{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:57:24Z","timestamp":1780667844894,"version":"3.54.1"},"reference-count":45,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>Inhaled amiloride, a blocker of the epithelial sodium channel (<jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content>), enhances mucociliary clearance (<jats:styled-content style=\"fixed-case\">MCC<\/jats:styled-content>) in cystic fibrosis (<jats:styled-content style=\"fixed-case\">CF<\/jats:styled-content>) patients. However, the dose of amiloride is limited by the mechanism\u2010based side effect of hyperkalaemia resulting from renal <jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content> blockade. Inhaled <jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content> blockers with a reduced potential to induce hyperkalaemia provide a therapeutic strategy to improve mucosal hydration and <jats:styled-content style=\"fixed-case\">MCC<\/jats:styled-content> in the lungs of <jats:styled-content style=\"fixed-case\">CF<\/jats:styled-content> patients. The present study describes the preclinical profile of a novel <jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content> blocker, <jats:styled-content style=\"fixed-case\">NVP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">QBE<\/jats:styled-content>170, designed for inhaled delivery, with a reduced potential to induce hyperkalaemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>The <jats:italic>in vitro<\/jats:italic> potency and duration of action of <jats:styled-content style=\"fixed-case\">NVP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">QBE<\/jats:styled-content>170 were compared with amiloride and a newer ENaC blocker, P552\u201002, in primary human bronchial epithelial cells (<jats:styled-content style=\"fixed-case\">HBEC<\/jats:styled-content>s) by short\u2010circuit current. <jats:italic>In vivo<\/jats:italic> efficacy and safety were assessed in guinea pig (tracheal potential difference\/hyperkalaemia), rat (hyperkalaemia) and sheep (<jats:styled-content style=\"fixed-case\">MCC<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\"><jats:italic>I<\/jats:italic><\/jats:styled-content><jats:italic>n vitro<\/jats:italic>, <jats:styled-content style=\"fixed-case\">NVP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">QBE<\/jats:styled-content>170 potently inhibited <jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content> function in <jats:styled-content style=\"fixed-case\">HBEC<\/jats:styled-content> and showed a longer duration of action to comparator molecules. <jats:italic>In vivo<\/jats:italic>, intratracheal (i.t.) instillation of <jats:styled-content style=\"fixed-case\">NVP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">QBE<\/jats:styled-content>170 attenuated <jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content> activity in the guinea pig airways with greater potency and duration of action than that of amiloride without inducing hyperkalaemia in either guinea pig or rat. Dry powder inhalation of <jats:styled-content style=\"fixed-case\">NVP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">QBE<\/jats:styled-content>170 by conscious sheep increased <jats:styled-content style=\"fixed-case\">MCC<\/jats:styled-content> and was better than inhaled hypertonic saline in terms of efficacy and duration of action.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">NVP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">QBE<\/jats:styled-content>170 highlights the potential for inhaled <jats:styled-content style=\"fixed-case\">ENaC<\/jats:styled-content> blockers to exhibit efficacy in the airways with a reduced risk of hyperkalaemia, relative to existing compounds.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.13075","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T11:49:57Z","timestamp":1420804197000},"page":"2814-2826","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["<scp>NVP<\/scp>\u2010<scp>QBE<\/scp>170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia"],"prefix":"10.1111","volume":"172","author":[{"given":"K J","family":"Coote","sequence":"first","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Paisley","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Czarnecki","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tweed","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Watson","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Young","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sugar","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vyas","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Smith","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Baettig","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Groot\u2010Kormelink","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gosling","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lock","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ethell","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Williams","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Genomics Institute of the Novartis Foundation  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Harris","sequence":"additional","affiliation":[{"name":"Genomics Institute of the Novartis Foundation  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W M","family":"Abraham","sequence":"additional","affiliation":[{"name":"Department of Research Mount Sinai Medical Center  Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sabater","sequence":"additional","affiliation":[{"name":"Department of Research Mount Sinai Medical Center  Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C T","family":"Poll","sequence":"additional","affiliation":[{"name":"Retroscreen Virology Ltd  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Faller","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Collingwood","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Danahay","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research  Horsham UK"},{"name":"School of Life Sciences University of Sussex  Brighton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12447"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12451"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/141.3.605"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01744.x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1988.sp017322"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.73.5.427"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/361467a0"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0396-248"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.11.029"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.148155"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.363"},{"key":"e_1_2_10_13_1","first-page":"218","article-title":"Safety, pharmacokinetics and effects on mucus clearance following administration of 552\u201002 to normal healthy volunteers","volume":"40","author":"Donaldson S","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043891"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043900"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-9084(88)90196-4"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1183\/09031936.93.06091243","article-title":"No added benefit from nebulized amiloride in patients with cystic fibrosis","volume":"6","author":"Graham A","year":"1993","journal-title":"Eur Respir J"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(02)00161-8"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.071886"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.130443"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/jam.1997.10.147"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1106695108"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.2144\/02323st05"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2002"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907153410304"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112173052502"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004263221704"},{"key":"e_1_2_10_29_1","first-page":"319","article-title":"Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses","volume":"146","author":"K\u00f6hler D","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.032789"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1028"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81724-9"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.5.1283"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2013.1037"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1143"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00496-4"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-0496(200007)30:1<25::AID-PPUL5>3.0.CO;2-C"},{"key":"e_1_2_10_39_1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/clinchem\/35.5.726","article-title":"Defective epithelial ion transport in cystic fibrosis","volume":"35","author":"Quinton PM","year":"1989","journal-title":"Clin Chem"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2475911"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.109.1.15"},{"key":"e_1_2_10_42_1","first-page":"L405","article-title":"Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium","volume":"266","author":"Sheppard DN","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_10_43_1","first-page":"3","article-title":"Functional reconstitution of the human epithelial Na+ channel in a mammalian expression system","volume":"337","author":"Staruschenko A","year":"2006","journal-title":"Methods Mol Biol"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0696-248"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm900403j"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200803-442OC"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13075","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.13075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:46:49Z","timestamp":1694512009000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.13075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/bph.13075"],"URL":"https:\/\/doi.org\/10.1111\/bph.13075","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]},"assertion":[{"value":"2014-07-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}